«
»

News and press releases: European Medicines Agency recommends authorisation of first medicine specifically for irritable bowel syndrome

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the authorisation of the first medicine specifically for the symptomatic treatment of irritable bowel syndrome (IBS) in the European Union (EU).
Go to Source

Share and Enjoy:
  • Add to favorites
  • email
  • Print
  • Twitter
  • Facebook
  • Digg
  • StumbleUpon
  • del.icio.us
  • Yahoo! Buzz
  • Google Bookmarks
  • Google Buzz
  • FriendFeed
  • LinkedIn
  • Live
  • Posterous
  • Reddit
  • Technorati
  • Wikio


This entry was posted on Saturday, October 13th, 2012 at 11:30 pm and is filed under European Medicines Agency. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.

Comments are closed.

Leave a Reply

You must be logged in to post a comment.

MySQL query error